John Alexander Kelly - Net Worth and Insider Trading

John Alexander Kelly Net Worth

The estimated net worth of John Alexander Kelly is at least $270,699 dollars as of 2024-11-29. John Alexander Kelly is the CFO of Precision BioSciences Inc and owns about 38,073 shares of Precision BioSciences Inc (DTIL) stock worth over $270,699. Details can be seen in John Alexander Kelly's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that John Alexander Kelly has not made any transactions after 2024-11-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of John Alexander Kelly

To

John Alexander Kelly Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, John Alexander Kelly owns 1 companies in total, including Precision BioSciences Inc (DTIL) .

Click here to see the complete history of John Alexander Kelly’s form 4 insider trades.

Insider Ownership Summary of John Alexander Kelly

Ticker Comapny Transaction Date Type of Owner
DTIL Precision BioSciences Inc 2024-11-21 Interim CFO

John Alexander Kelly Latest Holdings Summary

John Alexander Kelly currently owns a total of 1 stock. John Alexander Kelly owns 38,073 shares of Precision BioSciences Inc (DTIL) as of November 21, 2024, with a value of $270,699.

Latest Holdings of John Alexander Kelly

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DTIL Precision BioSciences Inc 2024-11-21 38,073 7.11 270,699

Holding Weightings of John Alexander Kelly


John Alexander Kelly Form 4 Trading Tracker

According to the SEC Form 4 filings, John Alexander Kelly has made a total of 6 transactions in Precision BioSciences Inc (DTIL) over the past 5 years, including 6 buys and 0 sells. The most-recent trade in Precision BioSciences Inc is the acquisition of 3,000 shares on November 21, 2024, which cost John Alexander Kelly around $20,280.

Insider Trading History of John Alexander Kelly

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

John Alexander Kelly Trading Performance

GuruFocus tracks the stock performance after each of John Alexander Kelly's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by John Alexander Kelly is -26.23%. GuruFocus also compares John Alexander Kelly's trading performance to market benchmark return within the same time period. The performance of stocks bought by John Alexander Kelly within 3 months outperforms 0 times out of 5 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how John Alexander Kelly's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of John Alexander Kelly

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 5 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -3.85 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.74 LIMIT LIMIT LIMIT LIMIT LIMIT

John Alexander Kelly Ownership Network

Ownership Network List of John Alexander Kelly

No Data

Ownership Network Relation of John Alexander Kelly

Insider Network Chart

John Alexander Kelly Owned Company Details

What does Precision BioSciences Inc do?

Who are the key executives at Precision BioSciences Inc?

John Alexander Kelly is the Interim CFO of Precision BioSciences Inc. Other key executives at Precision BioSciences Inc include director & President and CEO Michael Amoroso , General Counsel Dario Scimeca , and 10 percent owner J. Jefferson Smith .

Precision BioSciences Inc (DTIL) Insider Trades Summary

Over the past 18 months, John Alexander Kelly made 2 insider transaction in Precision BioSciences Inc (DTIL) with a net purchase of 93,000. Other recent insider transactions involving Precision BioSciences Inc (DTIL) include a net sale of 51,624 shares made by Dario Scimeca , a net sale of 266,953 shares made by Michael Amoroso , and a net sale of 28,204 shares made by J. Jefferson Smith .

In summary, during the past 3 months, insiders sold 3,600 shares of Precision BioSciences Inc (DTIL) in total and bought 3,000 shares, with a net sale of 600 shares. During the past 18 months, 18,310 shares of Precision BioSciences Inc (DTIL) were sold and 6,000 shares were bought by its insiders, resulting in a net sale of 12,310 shares.

Precision BioSciences Inc (DTIL)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Precision BioSciences Inc Insider Transactions

No Available Data

John Alexander Kelly Mailing Address

Above is the net worth, insider trading, and ownership report for John Alexander Kelly. You might contact John Alexander Kelly via mailing address: C/o Forest Laboratories, Inc., 909 Third Avenue, New York Ny 10022.

Discussions on John Alexander Kelly

No discussions yet.